Olmesartan Medoxomil Krka

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Krka, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension and may be prescribed for adults requiring blood pressure control.

GNH USA supplies Olmesartan Medoxomil Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxomil is an antihypertensive agent that acts on the renin‑angiotensin system to lower blood pressure. - Hypertension: helps lower systolic and diastolic blood pressure in adult patients. - Diabetic nephropathy risk reduction: may slow progression of kidney damage associated with diabetes. - Stroke prevention: contributes to reduced risk of stroke in patients with high blood pressure.

Adverse reactions to olmesartan medoxil are generally mild to moderate, but serious events can occur.

Common Side Effects: - Dizziness or light‑headed ​. - Headache. - Fatigue. - Nasal congestion. - Diarrhoea. - Elevated blood‑glucose levels.

Serious or Rare Side Effects: - Angio‑edema involving the face, lips or tongue. - Severe hypotension. - Acute kidney injury. - Liver enzyme abnormalities. - Allergic skin reactions such as Stevens‑Johnson syndrome. - Myocardial infarction in patients with pre‑existing coronary disease.

When using Olmers...

The